These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23172728)

  • 21. High Basal Levels of γH2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair.
    Vallabhaneni H; Lynch PJ; Chen G; Park K; Liu Y; Goehe R; Mallon BS; Boehm M; Hursh DA
    Stem Cells; 2018 Oct; 36(10):1501-1513. PubMed ID: 29873142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
    Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
    Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
    Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
    Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced pluripotent stem cells are sensitive to DNA damage.
    Zhang M; Yang C; Liu H; Sun Y
    Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):320-6. PubMed ID: 24100274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [iPS Cell Technology for Dissecting Mechanisms of Cancer Development].
    Nakasuka F; Yamada Y
    Gan To Kagaku Ryoho; 2020 Oct; 47(10):1407-1410. PubMed ID: 33130730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Insight into Reprogramming Barriers to iPSC Generation.
    Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.
    Rohani L; Johnson AA; Naghsh P; Rancourt DE; Ulrich H; Holland H
    Stem Cells Transl Med; 2018 Dec; 7(12):867-875. PubMed ID: 30218497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hotspots of De Novo Point Mutations in Induced Pluripotent Stem Cells.
    Yoshihara M; Araki R; Kasama Y; Sunayama M; Abe M; Nishida K; Kawaji H; Hayashizaki Y; Murakawa Y
    Cell Rep; 2017 Oct; 21(2):308-315. PubMed ID: 29020618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion/deletion and microsatellite alteration profiles in induced pluripotent stem cells.
    Kamimura S; Suga T; Hoki Y; Sunayama M; Imadome K; Fujita M; Nakamura M; Araki R; Abe M
    Stem Cell Reports; 2021 Oct; 16(10):2503-2519. PubMed ID: 34559999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cell modeling of malignant hematopoiesis.
    Chao MP; Majeti R
    Exp Hematol; 2019 Mar; 71():68-76. PubMed ID: 30659850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.